We also evaluate the prognostic utility of NFL and NFH in MND compared to clinical prognostic tools and, finally, determine the utility of serum NFL and NFH in differentiating ALS from PMA and PLS. This evidence concerns the gene NEFH and mild neurocognitive disorder.